Using computer-assisted music to help young patients with their first psychotic episode

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the effects of computer-assisted music remediation on cognitive functioning in young patients experiencing their first psychotic episode. It aims to assess whether musical interventions can improve cognitive deficits, particularly memory issues, in this population. The study involves patients aged 18 to 30 who have been clinically stabilized and have shown memory deficits in neuropsychological assessments. Participants will engage in music-based cognitive remediation as part of their treatment plan at the CHU de Caen.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient aged 18 to 30 years.
* Consult for a first psychotic episode according to the criteria of the DSM-V
* Francophone patient
* With at least one memory deficit highlighted at the neuropsychological assessment of entry into the EMSI
* Benefiting from a follow-up within the EMSI
* Affiliated to the social security system
* Clinically stabilized patient one month away from psychiatric hospitalization
* Patient who has been informed of the study and has given his informed consent.

Exclusion Criteria:

Inability to give the patient informed information

* Not meeting the criteria of the DSM-V of first episode of psychosis
* Absence of memory cognitive disorders at the neuropsychological assessment of entry into the EMSI department.
* Patient who has already had cognitive remediation in his EMSI management.
* Patients under judicial protection measure (guardianship or curatorship).

Where it's running

• CAEN University Hospital
  Caen, France Recruiting

Study contacts

• Study coordinator: MEKIDICHE-VARGAS Leïla, Diploma in Practical Nursing
• Email: vargas-l@chu-caen.fr
• Phone: 0761883207

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Add CBD to antipsychotic treatment for first-episode psychosis to see if it helps more than placebo

  This study tests whether adding cannabidiol (CBD) to ongoing antipsychotic treatment helps people with a first episode of psychosis who haven’t fully responded to their first antipsychotic, compared with a placebo.

  Recruiting at 2 sites Phase 3 University of Oxford · Vienna and 16 other locations · NCT06778564

• Early identification program for first-episode psychosis

  This study tests a program that helps people with early signs of psychosis get the care they need faster to improve their chances of recovery.

  Recruiting at 6 sites Centre Hospitalier Universitaire de Saint Etienne · Bron and 5 other locations · NCT05813457

• Impact of case manager intervention on psychotic episode recurrence in young adults

  This study tests whether having a trained case manager can help young adults aged 16 to 30 who have had their first psychotic episode avoid having more episodes.

  Recruiting at 3 sites Centre Hospitalier Universitaire de Nīmes · Toulouse, Choisir Une Région and 5 other locations · NCT05116514

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.